FDA's Prasad becoming agency's chief medical and scientific officer

FDA Commissioner Marty Makary has told staff that Center for Biologics Evaluation and Research Director Vinay Prasad has been given two additional roles: chief medical officer and chief scientific officer.
“Dr. Prasad will also provide senior medical and scientific input to me on cross-center medical policy and regulatory decisions, and he will act as a senior medical and scientific representative at national, international, or advisory committee meetings, and forums related to public health, regulatory science, and innovation,” Makary wrote in a June 18 email reviewed by Regulatory Focus.
The communication added that he will work with Makary and senior staff on “cross-cutting and emerging medical and scientific issues” impacting the agency.
In the past, chief medical officer and chief scientific officer have been separate roles. Steven Kozlowski is currently the agency’s acting chief scientist, and the CMO position has been vacant since April when Hilary Marston announced on a LinkedIn post she was leaving due to agency cuts.
The move comes after Prasad recently joined the agency in May following the abrupt resignation of long-time CBER leader Peter Marks.

FDA’s Prasad becoming agency’s chief medical and scientific officer